Clinuvel Pharmaceuticals | CUV - Ebitda

Harga Saham

9.13

Perubahan Harian

-0.10 -1.08%

Bulanan

-5.49%

Tahunan

-13.79%

Q2 Perkiraan

8.91

Keuangan

AUD

AUD 269.7M

AUD 35.2M

Biaya Penjualan

AUD 2.64M

AUD 261.38M

Kewajiban Lancar

AUD 17.85M

AUD 879.78K

Dividen - Hasil

0.57

AUD 13.51M

AUD 27.55M

16

Eps Laba Per Saham

AUD 0.21

Modal Dan Cadangan

AUD 249.02M

Laba Kotor Pada Penjualan

AUD 57.82M

Beban Bunga Utang

AUD 2.49M

AUD 17.25K

Kapitalisasi Pasar

AUD 462.06M

Batas Pemasukan

AUD 10.44M

Biaya Operasional

AUD 23.42M

Laba Operasional

AUD 13.51M

Modal Saham Biasa

AUD 50.2M

Pe Harga Untuk Laba

19.34

Laba Sebelum Pajak

AUD 28.8M

Pendapatan Penjualan

AUD 36.93M

Beban Penjualan Dan Administrasi

AUD 3.85M

AUD 9.52M

Kreditur Perdagangan

AUD 10.68M

Debitur Perdagangan

AUD 16.58M

	Ebitda	Perubahan		Tanggal
Avita Medical	AUD -9.69M		12.21M	2025-12
Medical Developments International	AUD 1.78M		3.78M	2024-12
Mesoblast	USD -20.3M		2.51M	2025-12
Neuren Pharmaceuticals	AUD 11.14M		165.56M	2025-12
Pacific Edge	NZD -13.97M		332K	2024-09
Paradigm Biopharmaceuticals	AUD -5.86M		3.79M	2024-12
PYC Therapeutics	AUD -22.79M		1.5M	2025-12
Telix Pharmaceuticals	AUD 18.42M		14.82M	2025-12